Print

Intellect Neurosciences, Inc. Issues Letter to Shareholders  
10/16/2012 9:36:34 AM

NEW YORK, Oct. 16, 2012 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for proteinopathies, today issued the following Letter to Shareholders from Dr. Daniel Chain, Chairman and CEO.
//-->